NextGen Healthcare, Inc.
NXGN · NASDAQ
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $653 | $596 | $557 | $540 |
| % Growth | 9.5% | 7.1% | 3.1% | – |
| Cost of Goods Sold | $342 | $295 | $275 | $267 |
| Gross Profit | $311 | $301 | $281 | $273 |
| % Margin | 47.6% | 50.5% | 50.5% | 50.5% |
| R&D Expenses | $82 | $77 | $76 | $83 |
| G&A Expenses | $213 | $203 | $177 | $159 |
| SG&A Expenses | $223 | $210 | $181 | $165 |
| Sales & Mktg Exp. | $10 | $7 | $4 | $6 |
| Other Operating Expenses | $4 | $4 | $4 | $4 |
| Operating Expenses | $309 | $290 | $260 | $253 |
| Operating Income | $16 | $11 | $21 | $21 |
| % Margin | 2.5% | 1.9% | 3.8% | 3.9% |
| Other Income/Exp. Net | $8 | -$6 | -$10 | -$15 |
| Pre-Tax Income | $4 | $5 | $9 | $4 |
| Tax Expense | $7 | $4 | -$0 | -$3 |
| Net Income | -$3 | $2 | $10 | $7 |
| % Margin | -0.4% | 0.3% | 1.7% | 1.4% |
| EPS | -0.04 | 0.02 | 0.14 | 0.11 |
| % Growth | -300% | -85.7% | 27.3% | – |
| EPS Diluted | -0.04 | 0.02 | 0.14 | 0.11 |
| Weighted Avg Shares Out | 66 | 67 | 67 | 65 |
| Weighted Avg Shares Out Dil | 67 | 68 | 67 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $0 | $0 | $0 |
| Interest Expense | $6 | $1 | $4 | $2 |
| Depreciation & Amortization | $37 | $42 | $49 | $4 |
| EBITDA | $48 | $53 | $70 | $25 |
| % Margin | 7.4% | 9% | 12.6% | 4.7% |